  |
Items where Author is "Csige, Katalin"
Group by: Item Type | No Grouping Jump to: Article Number of items: 3. ArticlePéliné Szabó, Judit and Csige, Katalin and Kálmán-Szabó, Ibolya and Arató, Viktória Zsófia and Opposits, Gábor and Képes, Zita and Méhes, Gábor and Fenyvesi, Ferenc and Hajdu, István and Trencsényi, György (2023) In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 630. ISSN 0378-5173 Csige, Katalin and Péliné Szabó, Judit and Kálmán-Szabó, Ibolya and Dénes, Noémi and Szikra, Dezső and Képes, Zita and Opposits, Gábor and Méhes, Gábor and Kertész, István and Fenyvesi, Ferenc and Trencsényi, György and Hajdu, István (2022) In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 625. ISSN 0378-5173 Trencsényi, György and Kis, Adrienn and Szabó, Judit P. and Ráti, Ágnes and Csige, Katalin and Fenyvesi, Éva and Szente, Lajos and Malanga, Milo and Méhes, Gábor and Emri, Miklós and Kertész, István and Vecsernyés, Miklós and Fenyvesi, Ferenc and Hajdu, István (2020) In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography. International Journal of Pharmaceutics, 576. pp. 1-10. ISSN 0378-5173 |
